Sézary's disease: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 19: Line 19:
{{SK}} Cutaneous T-cell lymphoma; mycosis fungoides; sezary syndrome
{{SK}} Cutaneous T-cell lymphoma; mycosis fungoides; sezary syndrome


== [[Sezary's disease overview|Overview]] ==


== [[Sezary's disease historical perspective|Historical Perspective]]==
== [[Sezary's disease classification|Classification]] ==
== [[Sezary's disease pathophysiology|Pathophysiology]] ==
== [[Sezary's disease causes|Causes]] ==
== [[Sezary's disease differential diagnosis|Differentiating Sezary's Disease from other Diseases]] ==
== [[Sezary's disease epidemiology and demographics|Epidemiology and Demographics]]==
== [[Sezary's disease risk factors|Risk Factors]] ==
== [[Sezary's disease natural history, complications and prognosis|Natural History, Complications and Prognosis]] ==
== Diagnosis ==
[[Sezary's disease history and symptoms|History and Symptoms]] | [[Sezary's disease physical examination|Physical Examination]] | [[Sezary's disease laboratory findings|Laboratory Findings]] | [[Sezary's disease CT|CT]] | [[Sezary's disease other diagnostic studies|Other Diagnostic Studies]]
== Treatment ==
[[Sezary's disease medical therapy|Medical Therapy]] | [[Sezary's disease surgery|Surgery]] | [[Sezary's disease primary prevention|Prevention]] | [[Sezary's disease future or investigational therapies|Future or Investigational Therapies]] | [[Sezary's disease cost-effectiveness of therapy | Cost Effectiveness of Therapy]]
==Case Studies==
:[[Sezary's disease case study one|Case #1]]





Revision as of 15:39, 21 September 2012